Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus
   
   

The present invention is directed to certain diaryl amide compounds as NS3-Serine protease inhibitors of hepatitis C virus. A particularly preferred compound is of the formula: ##STR1##

 
Web www.patentalert.com

< Vaccine composition containing a promoter peptide

< Ribavirin-pegylated interferon alfa induction HCV combination therapy

> Methods and systems for producing recombinant viral antigens

> Conserved motif of hepatitis C virus E2/NS1 region
~ 00190